prof. dr. Philippe Gevaert

Sophie Scheire (UGent) , Sophie Germonpré (UGent) , Els Mehuys (UGent) , Inge Van Tongelen (UGent) , An De Sutter (UGent) , Stephane Steurbaut, Thierry Van Hees, Sophie Demarche, Lies Lahousse (UGent) , Philippe Gevaert (UGent) , et al.

(2024) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 12(7). p.1865-1876.e6

Add to list

Nonallergic rhinopathy : a comprehensive review of classification, diagnosis, and treatment

Fuad M. Baroody, Philippe Gevaert (UGent) , Peter K. Smith, Navid Ziaie and Jonathan A. Bernstein

(2024) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 12(6). p.1436-1447

Add to list

Journal Article
A1
open access

Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa

Jozefien Declercq (UGent) , Sarah Gerlo (UGent) , Sharon Van Nevel (UGent) , Natalie De Ruyck (UGent) , Gabriële Holtappels (UGent) , Liesbeth Delesie (UGent) , Els Tobback (UGent) , Inés Lammens (UGent) , Nikita Gerebtsov (UGent) , Koen Sedeyn (UGent) , et al.

(2024) SCIENCE TRANSLATIONAL MEDICINE. 16(770).

Academic Bibliography

prof. dr. Philippe Gevaert

Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials

Expert consensus on surgical management of primary diffuse type 2‐dominant chronic rhinosinusitis

Endotyping in chronic rhinosinusitis : an EAACI Task Force report

EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP

European biologic training course for type 2 inflammation by EUFOREA in 2024 : key facts and lessons learned

Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP

Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps : SYNAPSE 24‐week treatment‐free follow‐up

Rhinitis control and medication use in a real-world sample of patients with persistent rhinitis or rhinosinusitis : a community pharmacy study

Nonallergic rhinopathy : a comprehensive review of classification, diagnosis, and treatment

Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa

Contents

Support

Contact